List of Tables
Table 1. Glycosylated Biosimilars Market Trends
Table 2. Glycosylated Biosimilars Market Drivers & Opportunity
Table 3. Glycosylated Biosimilars Market Challenges
Table 4. Glycosylated Biosimilars Market Restraints
Table 5. Global Glycosylated Biosimilars Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Glycosylated Biosimilars Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Glycosylated Biosimilars Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Glycosylated Biosimilars Product Type
Table 9. Key Companies Time to Begin Mass Production of Glycosylated Biosimilars
Table 10. Global Glycosylated Biosimilars Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycosylated Biosimilars as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Glycosylated Biosimilars Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Glycosylated Biosimilars Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Glycosylated Biosimilars Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Glycosylated Biosimilars Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Glycosylated Biosimilars Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Glycosylated Biosimilars Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Glycosylated Biosimilars Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Glycosylated Biosimilars Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Glycosylated Biosimilars Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Glycosylated Biosimilars Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Glycosylated Biosimilars Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Glycosylated Biosimilars Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Glycosylated Biosimilars Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Glycosylated Biosimilars Sales Value by Region (2019-2024) & (%)
Table 27. Global Glycosylated Biosimilars Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Glycosylated Biosimilars Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Glycosylated Biosimilars Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Glycosylated Biosimilars Sales Value, (2025-2030) & (US$ Million)
Table 31. Sandoz Basic Information List
Table 32. Sandoz Description and Business Overview
Table 33. Sandoz Glycosylated Biosimilars Products, Services and Solutions
Table 34. Revenue (US$ Million) in Glycosylated Biosimilars Business of Sandoz (2019-2024)
Table 35. Sandoz Recent Developments
Table 36. Pfizer Basic Information List
Table 37. Pfizer Description and Business Overview
Table 38. Pfizer Glycosylated Biosimilars Products, Services and Solutions
Table 39. Revenue (US$ Million) in Glycosylated Biosimilars Business of Pfizer (2019-2024)
Table 40. Pfizer Recent Developments
Table 41. Teva Pahrmaceutical Basic Information List
Table 42. Teva Pahrmaceutical Description and Business Overview
Table 43. Teva Pahrmaceutical Glycosylated Biosimilars Products, Services and Solutions
Table 44. Revenue (US$ Million) in Glycosylated Biosimilars Business of Teva Pahrmaceutical (2019-2024)
Table 45. Teva Pahrmaceutical Recent Developments
Table 46. Celltrion Basic Information List
Table 47. Celltrion Description and Business Overview
Table 48. Celltrion Glycosylated Biosimilars Products, Services and Solutions
Table 49. Revenue (US$ Million) in Glycosylated Biosimilars Business of Celltrion (2019-2024)
Table 50. Celltrion Recent Developments
Table 51. Biocon Basic Information List
Table 52. Biocon Description and Business Overview
Table 53. Biocon Glycosylated Biosimilars Products, Services and Solutions
Table 54. Revenue (US$ Million) in Glycosylated Biosimilars Business of Biocon (2019-2024)
Table 55. Biocon Recent Developments
Table 56. Amgen Basic Information List
Table 57. Amgen Description and Business Overview
Table 58. Amgen Glycosylated Biosimilars Products, Services and Solutions
Table 59. Revenue (US$ Million) in Glycosylated Biosimilars Business of Amgen (2019-2024)
Table 60. Amgen Recent Developments
Table 61. Samsung Biologics Basic Information List
Table 62. Samsung Biologics Description and Business Overview
Table 63. Samsung Biologics Glycosylated Biosimilars Products, Services and Solutions
Table 64. Revenue (US$ Million) in Glycosylated Biosimilars Business of Samsung Biologics (2019-2024)
Table 65. Samsung Biologics Recent Developments
Table 66. Mylan Basic Information List
Table 67. Mylan Description and Business Overview
Table 68. Mylan Glycosylated Biosimilars Products, Services and Solutions
Table 69. Revenue (US$ Million) in Glycosylated Biosimilars Business of Mylan (2019-2024)
Table 70. Mylan Recent Developments
Table 71. Dr. Reddy's Laboratories Basic Information List
Table 72. Dr. Reddy's Laboratories Description and Business Overview
Table 73. Dr. Reddy's Laboratories Glycosylated Biosimilars Products, Services and Solutions
Table 74. Revenue (US$ Million) in Glycosylated Biosimilars Business of Dr. Reddy's Laboratories (2019-2024)
Table 75. Dr. Reddy's Laboratories Recent Developments
Table 76. Stada Arzneimittel AG Basic Information List
Table 77. Stada Arzneimittel AG Description and Business Overview
Table 78. Stada Arzneimittel AG Glycosylated Biosimilars Products, Services and Solutions
Table 79. Revenue (US$ Million) in Glycosylated Biosimilars Business of Stada Arzneimittel AG (2019-2024)
Table 80. Stada Arzneimittel AG Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Glycosylated Biosimilars Downstream Customers
Table 84. Glycosylated Biosimilars Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Glycosylated Biosimilars Product Picture
Figure 2. Global Glycosylated Biosimilars Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Glycosylated Biosimilars Sales Value (2019-2030) & (US$ Million)
Figure 4. Glycosylated Biosimilars Report Years Considered
Figure 5. Global Glycosylated Biosimilars Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Glycosylated Biosimilars Revenue in 2023
Figure 7. Glycosylated Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. mAb Picture
Figure 9. EPO Picture
Figure 10. Global Glycosylated Biosimilars Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Glycosylated Biosimilars Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Oncology
Figure 13. Product Picture of Chronic Diseases
Figure 14. Product Picture of Autoimmune Diseases
Figure 15. Product Picture of Blood Disorders
Figure 16. Product Picture of Growth Hormone Deficiency
Figure 17. Product Picture of Infectious Diseases
Figure 18. Product Picture of Other Diseases
Figure 19. Global Glycosylated Biosimilars Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Glycosylated Biosimilars Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Glycosylated Biosimilars Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Glycosylated Biosimilars Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Glycosylated Biosimilars Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Glycosylated Biosimilars Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Glycosylated Biosimilars Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Glycosylated Biosimilars Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Glycosylated Biosimilars Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Glycosylated Biosimilars Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Glycosylated Biosimilars Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Glycosylated Biosimilars Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Glycosylated Biosimilars Sales Value (%), (2019-2030)
Figure 32. United States Glycosylated Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Glycosylated Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Glycosylated Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Glycosylated Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Glycosylated Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Glycosylated Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 38. China Glycosylated Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Glycosylated Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 40. China Glycosylated Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Glycosylated Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Glycosylated Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Glycosylated Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Glycosylated Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Glycosylated Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Glycosylated Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Glycosylated Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Glycosylated Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Glycosylated Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 50. India Glycosylated Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Glycosylated Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 52. India Glycosylated Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 53. Glycosylated Biosimilars Industrial Chain
Figure 54. Glycosylated Biosimilars Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
